Leveraging Interleukin-1 Blockade as a Therapeutic Strategy for Cardiac Sarcoidosis: Rationale and Design for the RandomizEd PhAse II TrIal of Rilonacept in Subjects With Cardiac Sarcoidosis (REPAIR-CS).

Detalles Bibliográficos
Publicado en:	Journal of Cardiac Failure Vol. 32; no. 5; pp. 877 - 888
Autores principales:	ROSENBAUM, ANDREW N., WAGLE, ANJALI, MEUTH, COURTNEY L., WANG, SHELDON, PAOLINI, JOHN F., BRATCHER, MELANIE A., CHAREONTHAITAWEE, PANITHAYA, GILOTRA, NISHA A.
Formato:	Journal Article
Publicado:	W B Saunders May2026
Acceso en línea:	Ver este registro en EBSCOhost